Getein Biotech Inc
SSE:603387

Watchlist Manager
Getein Biotech Inc Logo
Getein Biotech Inc
SSE:603387
Watchlist
Price: 9.02 CNY 0.78% Market Closed
Updated: Jun 1, 2024
Section:
 

Relative Value

The Relative Value of one Getein Biotech Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 9.02 CNY, Getein Biotech Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Getein Biotech Inc Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

3.5
P/S
P/S
Price to Sales
3.5
vs History
80
vs Industry
71
Median 3Y
4
Median 5Y
4
Industry
7.8
Forward
2.8
More Details
18.7
P/E
P/E
Price to Earnings
18.7
vs History
15
vs Industry
8
Median 3Y
16.8
Median 5Y
13.6
Industry
24.7
Forward
11.2
More Details
11.8
P/OCF
P/OCF
Price to OCF
11.8
vs History
96
vs Industry
12
Median 3Y
14.2
Median 5Y
16.6
Industry
23.6
More Details
22.6
P/FCFE
P/FCFE
Price to FCFE
22.6
vs History
46
vs Industry
7
Median 3Y
23.5
Median 5Y
21.9
Industry
22.6
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
95
vs Industry
49
Median 3Y
2.7
Median 5Y
2.4
Industry
2.5
More Details
3.2
EV/S
EV/S
Enterprise Value to Sales
3.2
vs History
58
vs Industry
63
Median 3Y
3.6
Median 5Y
3.4
Industry
7.1
Forward
2.5
More Details
4.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.8
vs History
52
vs Industry
56
Median 3Y
5.6
Median 5Y
5.1
Industry
8.7
More Details
20.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.6
vs History
14
vs Industry
6
Median 3Y
14.5
Median 5Y
10.2
Industry
4.6
More Details
20.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.6
vs History
14
vs Industry
6
Median 3Y
14.5
Median 5Y
10.2
Industry
4.5
More Details
10.8
EV/OCF
EV/OCF
Enterprise Value to OCF
10.8
vs History
90
vs Industry
12
Median 3Y
12.8
Median 5Y
13.7
Industry
6.3
More Details
33.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
33.3
vs History
52
vs Industry
5
Median 3Y
29.1
Median 5Y
33.3
Industry
3.9
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
96
vs Industry
52
Median 3Y
2.7
Median 5Y
2.9
Industry
4.6
More Details

Multiples Across Competitors

Competitors Multiples
Getein Biotech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Getein Biotech Inc
SSE:603387
4.6B CNY 3.5 18.7 20.6 20.6
US
Abbvie Inc
NYSE:ABBV
284.7B USD 5.2 47.8 13.4 20.7
US
Amgen Inc
NASDAQ:AMGN
164.1B USD 5.6 43.6 18.4 30.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.6B USD 11.5 29.3 24.6 25.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
108B USD 8.2 28 22.6 25.1
AU
CSL Ltd
ASX:CSL
135.3B AUD 6.3 36.4 22 27.3
US
Gilead Sciences Inc
NASDAQ:GILD
80.1B USD 2.9 165.5 8.4 11.1
US
Moderna Inc
NASDAQ:MRNA
54.6B USD 10.6 -9.1 -10.2 -9.1
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
32.8B USD 3.4 28.1 14.3 17.9
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 142,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.